Vedat Aytekin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vedat Aytekin has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
- Alparslan Kilic
Department of Cardiology, Koc University Hospital, Istanbul, Turkey
5 shared publications - Onur Baydar
Department of Cardiology, Koc University Hospital, Istanbul, Turkey
5 shared publications - Saide Aytekin
Department of Cardiology, Koc University School of Medicine and Hospital, Istanbul, Turkey
5 shared publications - Erol Gürsoy
KOÇ ÜNİVERSİTESİ, TIP FAKÜLTESİ
4 shared publications - Betül Cengiz Elçioğlu
Department of Cardiology Koç University Hospital Istanbul Turkey
3 shared publications - Yasemin Demirci
Department of Cardiology Koc University School of Medicine Istanbul Türkiye
3 shared publications
Latest Publications
- 23 March 2026
- Published by Academician Publishing
- p. 589-598
Mitral ve Triküspit Kapak Hastalıklarında Perkütan Tedavi
- 23 March 2026
- Published by Academician Publishing
- p. 589-598
Mitral ve Triküspit Kapak Hastalıklarında Perkütan Tedavi
- 23 March 2026
- Published by Academician Publishing
- p. 773-810
Girişimsel Kardiyoloji ve Perkütan İntrakoroner Girişimler
- 23 March 2026
- Published by Academician Publishing
- p. 773-810
Girişimsel Kardiyoloji ve Perkütan İntrakoroner Girişimler
- 23 March 2026
- Published by Academician Publishing
- p. 633-640
Erişkin Perkütan Kapak Girişimleri
- Open Access
- 9 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (2) , e47028
Effects of traumatic stress on endothelial and cardiac autonomic functions
Traumatic stress is a psychobiological response to an overwhelming life event that exceeds the individual’s capacity to cope. Emerging evidence suggests that exposure to traumatic stress: whether or not it results in post-traumatic stress disorder (PTSD) is associated with increased cardiovascular risk. This study aimed to examine the relationship between trauma-related psychiatric symptoms and markers of endothelial and cardiac autonomic function. A list of potentially traumatic life events and the self-report PTSD Symptom Checklist-5 were administered to 132 adults. To evaluate the endothelial function, carotid intima media thickness (CIMT) and flow mediated dilatation were measured for all participants. Additionally, the Ewing test results, heart rate (HR), blood pressure, and biochemical parameters were collected. Those who reported at least 1 stressor event of traumatic scope (n = 48, 36%) were compared to those who did not (n = 84, 64%) alongside participants with and without a diagnosis of PTSD. Carotid intima media thickness (0.61 mm [0.32–0.82] vs 0.41 mm [0.28–0.69], P < .0005), systolic blood pressure (SBP) (125 mm Hg [109–130] vs 114 mm Hg [95–130], P < .0005), morning HR (81 bpm [61–96] vs 77 bpm [50–100], P = .042), serum C-reactive protein (CRP, 1.40 mg/L [0.30–5.30] vs 0.30 mg/L [0.30–4.10], P = .014) values were significantly increased in the traumatic stressor group compared to the non-stressor group. Flow mediated dilatation values (8% [4–16] vs 11% [4–23], P < .0005) were lower in the traumatic stressor group than the non-stressor group. Presence of traumatic stress was positively correlated with CIMT ( R = 0.56, P < .0005), CRP ( R = 0.22, P = .03), and SBP ( R = 0.41, P < .0005). Presence of traumatic stress was negatively correlated with flow mediated dilatation ( r = −0.35, P < .0005). According to the logistic regression analysis, SBP, CIMT, and flow mediated dilatation values were independently associated with traumatic stress. The Diagnostic and Statistical Manual of Mental Disorders-5 diagnosis of PTSD (n = 19, 14%) and PTSD symptom total scores (mean = 22.3, SD = 16.1) were, however, not associated with any of the assessed biological variables. Trauma exposure regardless of PTSD diagnosis was independently associated with early signs of vascular dysfunction and elevated cardiovascular risk markers (SBP, CIMT, and flow mediated dilatation). Morever, morning HR and serum CRP values were found significantly different between the participants with and without a history of traumatic stress. These findings underscore the need to consider trauma history in cardiovascular risk assessment, even in the absence of clinically diagnosed PTSD.
- 9 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (2) , e47028
Open AccessEffects of traumatic stress on endothelial and cardiac autonomic functions
Traumatic stress is a psychobiological response to an overwhelming life event that exceeds the individual’s capacity to cope. Emerging evidence suggests that exposure to traumatic stress: whether or not it results in post-traumatic stress disorder (PTSD) is associated with increased cardiovascular risk. This study aimed to examine the relationship between trauma-related psychiatric symptoms and markers of endothelial and cardiac autonomic function. A list of potentially traumatic life events and the self-report PTSD Symptom Checklist-5 were administered to 132 adults. To evaluate the endothelial function, carotid intima media thickness (CIMT) and flow mediated dilatation were measured for all participants. Additionally, the Ewing test results, heart rate (HR), blood pressure, and biochemical parameters were collected. Those who reported at least 1 stressor event of traumatic scope (n = 48, 36%) were compared to those who did not (n = 84, 64%) alongside participants with and without a diagnosis of PTSD. Carotid intima media thickness (0.61 mm [0.32–0.82] vs 0.41 mm [0.28–0.69], P < .0005), systolic blood pressure (SBP) (125 mm Hg [109–130] vs 114 mm Hg [95–130], P < .0005), morning HR (81 bpm [61–96] vs 77 bpm [50–100], P = .042), serum C-reactive protein (CRP, 1.40 mg/L [0.30–5.30] vs 0.30 mg/L [0.30–4.10], P = .014) values were significantly increased in the traumatic stressor group compared to the non-stressor group. Flow mediated dilatation values (8% [4–16] vs 11% [4–23], P < .0005) were lower in the traumatic stressor group than the non-stressor group. Presence of traumatic stress was positively correlated with CIMT ( R = 0.56, P < .0005), CRP ( R = 0.22, P = .03), and SBP ( R = 0.41, P < .0005). Presence of traumatic stress was negatively correlated with flow mediated dilatation ( r = −0.35, P < .0005). According to the logistic regression analysis, SBP, CIMT, and flow mediated dilatation values were independently associated with traumatic stress. The Diagnostic and Statistical Manual of Mental Disorders-5 diagnosis of PTSD (n = 19, 14%) and PTSD symptom total scores (mean = 22.3, SD = 16.1) were, however, not associated with any of the assessed biological variables. Trauma exposure regardless of PTSD diagnosis was independently associated with early signs of vascular dysfunction and elevated cardiovascular risk markers (SBP, CIMT, and flow mediated dilatation). Morever, morning HR and serum CRP values were found significantly different between the participants with and without a history of traumatic stress. These findings underscore the need to consider trauma history in cardiovascular risk assessment, even in the absence of clinically diagnosed PTSD.
- Open Access
- 12 September 2024
- Published by Wiley in Clinical Cardiology
- Vol. 47 (9) , e70012
Is There a Need for Sex‐Tailored Lipoprotein(a) Cut‐Off Values for Coronary Artery Disease Risk Stratification?
Background: Lipoprotein(a) [Lp(a)] plasma level is a well‐known risk factor for coronary artery disease (CAD). Existing data regarding the influence of sex on the Lp(a)‐CAD relationship are inconsistent.Objective: To investigate the relationship between Lp(a) and CAD in men and women and to elucidate any sex‐specific differences that may exist.Methods: Data of patients with Lp(a) measurements who were admitted to a tertiary university hospital, Koc University Hospital, were analyzed. The relationship between Lp(a) levels and CAD was explored in all patients and in subgroups created by sex. Two commonly accepted Lp(a) thresholds ≥ 30 and ≥ 50 mg/dL were analyzed.Results: A total of 1858 patients (mean age 54 ± 17 years; 53.33% females) were included in the analysis. Lp(a) was an independent predictor of CAD according to the multivariate regression model for the entire cohort. In all cohort, both cut‐off values (≥ 30 and ≥ 50 mg/dL) were detected as independent predictors of CAD (p < 0.001). In sex‐specific analysis, an Lp(a) ≥ 30 mg/dL was an independent predictor of CAD only in women (p < 0.001), but Lp(a) ≥ 50 mg/dL was a CAD predictor both in men and women (men, p = 0.004; women, p = 0.047).Conclusion: The findings of this study may suggest that different thresholds of Lp(a) level can be employed for risk stratification in women compared to men.
- 12 September 2024
- Published by Wiley in Clinical Cardiology
- Vol. 47 (9) , e70012
Open AccessIs There a Need for Sex‐Tailored Lipoprotein(a) Cut‐Off Values for Coronary Artery Disease Risk Stratification?
Background: Lipoprotein(a) [Lp(a)] plasma level is a well‐known risk factor for coronary artery disease (CAD). Existing data regarding the influence of sex on the Lp(a)‐CAD relationship are inconsistent.Objective: To investigate the relationship between Lp(a) and CAD in men and women and to elucidate any sex‐specific differences that may exist.Methods: Data of patients with Lp(a) measurements who were admitted to a tertiary university hospital, Koc University Hospital, were analyzed. The relationship between Lp(a) levels and CAD was explored in all patients and in subgroups created by sex. Two commonly accepted Lp(a) thresholds ≥ 30 and ≥ 50 mg/dL were analyzed.Results: A total of 1858 patients (mean age 54 ± 17 years; 53.33% females) were included in the analysis. Lp(a) was an independent predictor of CAD according to the multivariate regression model for the entire cohort. In all cohort, both cut‐off values (≥ 30 and ≥ 50 mg/dL) were detected as independent predictors of CAD (p < 0.001). In sex‐specific analysis, an Lp(a) ≥ 30 mg/dL was an independent predictor of CAD only in women (p < 0.001), but Lp(a) ≥ 50 mg/dL was a CAD predictor both in men and women (men, p = 0.004; women, p = 0.047).Conclusion: The findings of this study may suggest that different thresholds of Lp(a) level can be employed for risk stratification in women compared to men.
- Open Access
- 27 October 2023
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 5 (4) , 464-469
Evaluation of cardiovascular risk factors, prevalence and determinants of coronary artery disease in renal transplant patients: a single center experience
Aims: Cardiovascular disease is the leading cause of morbidity and mortality in renal transplant patients. In our study, we aimed to determine the cardiovascular (CV) risk factors, the prevalence and determinants of coronary artery disease (CAD) in patients who underwent kidney transplantation in our center. Methods: One hundred sixty nine patients who underwent kidney transplantation in our center were included in the study retrospectively. Demographic and clinical characteristics of the patients, cardiac evaluation findings and further examination results were scanned from the database of our center. Results: The mean age of the patients was 42.86±12.97 years and 43.19% were female. The most common etiological factors for the development of end-stage renal disease were hypertension (HT) and diabetes mellitus (DM). Ninety seven patients (57.4%) were undergoing dialysis, 4 of whom were on peritoneal dialysis. Renal transplant was performed from a cadaver in two patients and from a living donor in the other patients. CAD was detected in 29 patients (17.15%). The most prevalent CV risk factors were HT and hyperlipidemia (HL). Multivariate logistic regression analysis revealed that age, DM, HL and dialysis history were independent risk factors for the development of CAD. In the postoperative follow-ups, no death or acute coronary syndrome was observed during the hospitalization period. Conclusion: Prevalence of CV risk factors is high in renal transplant candidates. Our findings support the need for a detailed cardiac evaluation and effective management of CV risk factors in patients preparing for kidney transplantation.
- 27 October 2023
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 5 (4) , 464-469
Open AccessEvaluation of cardiovascular risk factors, prevalence and determinants of coronary artery disease in renal transplant patients: a single center experience
Aims: Cardiovascular disease is the leading cause of morbidity and mortality in renal transplant patients. In our study, we aimed to determine the cardiovascular (CV) risk factors, the prevalence and determinants of coronary artery disease (CAD) in patients who underwent kidney transplantation in our center. Methods: One hundred sixty nine patients who underwent kidney transplantation in our center were included in the study retrospectively. Demographic and clinical characteristics of the patients, cardiac evaluation findings and further examination results were scanned from the database of our center. Results: The mean age of the patients was 42.86±12.97 years and 43.19% were female. The most common etiological factors for the development of end-stage renal disease were hypertension (HT) and diabetes mellitus (DM). Ninety seven patients (57.4%) were undergoing dialysis, 4 of whom were on peritoneal dialysis. Renal transplant was performed from a cadaver in two patients and from a living donor in the other patients. CAD was detected in 29 patients (17.15%). The most prevalent CV risk factors were HT and hyperlipidemia (HL). Multivariate logistic regression analysis revealed that age, DM, HL and dialysis history were independent risk factors for the development of CAD. In the postoperative follow-ups, no death or acute coronary syndrome was observed during the hospitalization period. Conclusion: Prevalence of CV risk factors is high in renal transplant candidates. Our findings support the need for a detailed cardiac evaluation and effective management of CV risk factors in patients preparing for kidney transplantation.
- 21 May 2022
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 50 (6) , 749-755
Evaluation of pulmonary arterial stiffness and comparison with right ventricular functions in patients with cirrhosis preparing for liver transplantation
Objective: Pulmonary complications are common in patients with liver cirrhosis. Devolopment of pulmonary hypertension (PH) is associated with a poor prognosis in these patients. Pulmonary arterial stiffness (PAS) is considered an early sign of pulmonary vascular remodeling. The aim of this study is to investigate PAS and compare it with right ventricular (RV) functions in patients with cirrhosis who are scheduled for liver transplantation.Methods: The study included 52 cirrhosis patients (mean age 51.01 ± 12.18 years, male gender 76.9%) who were prepared for liver transplantation and 59 age and sex matched (mean age 51.28 ± 13.63 years, male gender 62.7%) healthy individuals. Patients with left ventricular ejection fraction (LVEF) less than 55%, ischemic heart disease, more than mild valvular heart disease, chronic pulmonary disease, congenital heart disease, rheumatic disease, moderate to high echocardiographic PH probability, rhythm or conduction disorders on electrocardiography were excluded from the study. In addition to conventional echocardiographic parameters, PAS value, pulmonary vascular resistance (PVR) and RV ejection efficiency was calculated by the related formulas with transthoracic echocardiography (TTE).Results: Demographic characteristics and cardiovascular risk factors of the groups were similar. PAS, PVR, and sPAP values were found to be significantly higher in the patient group (20.52 ± 6.52 and 13.73 ± 2.05; 1.43 ± 0.15 and 1.27 ± 0.14; 27.69 ± 3.91 and 23.37 ± 3.81 p < 0.001, respectively). RV FAC and RV Ee were significantly lower and RV MPI was significantly higher in the patient group (45.31 ± 3.85 and 49.66 ± 3.62, p < 0.001; 1.69 ± 0.35 and 1.85 ± 0.23, p = 0.005; 0.39 ± 0.07 and 0.33 ± 0.09, p = 0.001, respectively). PAS was significantly correlated with RV FAC and MPI (r = −0.423, p < 0.001; r = 0.301, p = 0.001, respectively).Conclusions: Increased PAS in cirrhosis patients may be associated with early pulmonary vascular involvement. Evaluation of RV functions is important to determine the prognosis in these patients. FAC, MPI, and RV Ee measurements instead of TAPSE or RV S′ may be more useful in demonstrating subclinical dysfunction. The correlation of PAS with RV FAC and MPI may indicate that RV subclinical dysfunction is associated with early pulmonary vascular remodeling in patients with liver cirrhosis.
- 21 May 2022
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 50 (6) , 749-755
Evaluation of pulmonary arterial stiffness and comparison with right ventricular functions in patients with cirrhosis preparing for liver transplantation
Objective: Pulmonary complications are common in patients with liver cirrhosis. Devolopment of pulmonary hypertension (PH) is associated with a poor prognosis in these patients. Pulmonary arterial stiffness (PAS) is considered an early sign of pulmonary vascular remodeling. The aim of this study is to investigate PAS and compare it with right ventricular (RV) functions in patients with cirrhosis who are scheduled for liver transplantation.Methods: The study included 52 cirrhosis patients (mean age 51.01 ± 12.18 years, male gender 76.9%) who were prepared for liver transplantation and 59 age and sex matched (mean age 51.28 ± 13.63 years, male gender 62.7%) healthy individuals. Patients with left ventricular ejection fraction (LVEF) less than 55%, ischemic heart disease, more than mild valvular heart disease, chronic pulmonary disease, congenital heart disease, rheumatic disease, moderate to high echocardiographic PH probability, rhythm or conduction disorders on electrocardiography were excluded from the study. In addition to conventional echocardiographic parameters, PAS value, pulmonary vascular resistance (PVR) and RV ejection efficiency was calculated by the related formulas with transthoracic echocardiography (TTE).Results: Demographic characteristics and cardiovascular risk factors of the groups were similar. PAS, PVR, and sPAP values were found to be significantly higher in the patient group (20.52 ± 6.52 and 13.73 ± 2.05; 1.43 ± 0.15 and 1.27 ± 0.14; 27.69 ± 3.91 and 23.37 ± 3.81 p < 0.001, respectively). RV FAC and RV Ee were significantly lower and RV MPI was significantly higher in the patient group (45.31 ± 3.85 and 49.66 ± 3.62, p < 0.001; 1.69 ± 0.35 and 1.85 ± 0.23, p = 0.005; 0.39 ± 0.07 and 0.33 ± 0.09, p = 0.001, respectively). PAS was significantly correlated with RV FAC and MPI (r = −0.423, p < 0.001; r = 0.301, p = 0.001, respectively).Conclusions: Increased PAS in cirrhosis patients may be associated with early pulmonary vascular involvement. Evaluation of RV functions is important to determine the prognosis in these patients. FAC, MPI, and RV Ee measurements instead of TAPSE or RV S′ may be more useful in demonstrating subclinical dysfunction. The correlation of PAS with RV FAC and MPI may indicate that RV subclinical dysfunction is associated with early pulmonary vascular remodeling in patients with liver cirrhosis.
- Open Access
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (3) , 754-761
Effects of iron deficiency on left ventricular functions in young women regardless of anemia: A speckle tracking echocardiography study
By BETÜL CENGİZ ELÇİOĞLU, ONUR BAYDAR, ALPARSLAN KILIÇ, et al., Published on 01/01/22
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (3) , 754-761
Open AccessEffects of iron deficiency on left ventricular functions in young women regardless of anemia: A speckle tracking echocardiography study
By BETÜL CENGİZ ELÇİOĞLU, ONUR BAYDAR, ALPARSLAN KILIÇ, et al., Published on 01/01/22
- Open Access
- 1 January 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 102, 389-391
Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
- 1 January 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 102, 389-391
Open AccessWhy we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?